We also examined SPRY4 mRNA expression in primary and metastatic melanoma tissue samples, obtained from the Oncomine database, and found that SPRY4 expression is decreased in metastasis compared to primary melanoma, which further suggests that SPRY4 inhibition is associated with melanoma metastasis development. This evidence concerns the gene SPRY4 and melanoma.